Some good news although a long way to go by the sounds of it.
As I have said in previous posts the Ardo range seems a good fit for the company under the banner of Clements. The announcement focuses on the pumps themselves but to use the pump a mum needs an attachment set ( a combination of tubes and cups that goes between the breast and the actual pump itself). These have to be replaced on a regular basis and will no doubt provide a further revenue stream for the company. I agree with Imsparticus, this endorsement will carry a lot of weight with new mums.
The loss of the Carefusion business announced earlier in the month will be hard to make up but it seems that the company had been preparing for the loss of this business for some time. The decision to increase their focus on the sale of their branded products – “Tuta” and “Clements”, makes a lot of sense. Also, given that the contract doesn’t expire until May the impact on this financial year should be minimal.
It seems that under Ellis the company has made steady progress since extricating itself from the Medivet mess. It also seems that there has been a lot of activity in the background (the identification of new product opportunities, the possibility of acquisitions etc.) but these have yet to impact the P&L. This announcement shows that there is upside. A few more similar announcements over the next six months or so should start to see greater movement on both the topline and the bottom-line – or at least in the first instance make up for the loss of the Carefusion business! Probably not much chance for significant changes this financial year but hopefully positioned well for 2017-18!
Looking forward to the 4D.
MLA Price at posting:
5.0¢ Sentiment: Buy Disclosure: Held
